Business Zenas BioPharma announces concurrent public offerings of convertible senior notes and common stock
Business Markets are making a ‘serious error’ by pricing in a fast resolution to the U.S.-Iran conflict
Business Lovesac outlines $700M–$750M fiscal 2027 sales target while advancing Made in America initiative